These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 37435061)
61. The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors. Veneziani I; Fruci D; Compagnone M; Pistoia V; Rossi P; Cifaldi L Oncotarget; 2019 Mar; 10(22):2151-2160. PubMed ID: 31040907 [TBL] [Abstract][Full Text] [Related]
62. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1. Lowin-Kropf B; Kunz B; Beermann F; Held W J Immunol; 2000 Aug; 165(3):1314-21. PubMed ID: 10903732 [TBL] [Abstract][Full Text] [Related]
63. Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice. Chiu DK; Yuen VW; Cheu JW; Wei LL; Ting V; Fehlings M; Sumatoh H; Nardin A; Newell EW; Ng IO; Yau TC; Wong CM; Wong CC Gastroenterology; 2020 Aug; 159(2):609-623. PubMed ID: 32275969 [TBL] [Abstract][Full Text] [Related]
65. Regulation of 2B4 (CD244)-mediated NK cell activation by ligand-induced receptor modulation. Sandusky MM; Messmer B; Watzl C Eur J Immunol; 2006 Dec; 36(12):3268-76. PubMed ID: 17111350 [TBL] [Abstract][Full Text] [Related]
66. CD155: A Multi-Functional Molecule in Tumor Progression. Molfetta R; Zitti B; Lecce M; Milito ND; Stabile H; Fionda C; Cippitelli M; Gismondi A; Santoni A; Paolini R Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019260 [TBL] [Abstract][Full Text] [Related]
67. NK cell receptor calibration: effects of MHC class I induction on killing by Ly49Ahigh and Ly49Alow NK cells. Olsson-Alheim MY; Salcedo M; Ljunggren HG; Kärre K; Sentman CL J Immunol; 1997 Oct; 159(7):3189-94. PubMed ID: 9317116 [TBL] [Abstract][Full Text] [Related]
68. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors. Lowin-Kropf B; Kunz B; Schneider P; Held W Eur J Immunol; 2002 Mar; 32(3):773-82. PubMed ID: 11870621 [TBL] [Abstract][Full Text] [Related]
69. Oncogenic nature of a novel mutant AATF and its interactome existing within human cancer cells. Sharma S; Kaul D; Arora M; Malik D Cell Biol Int; 2015 Mar; 39(3):326-33. PubMed ID: 25231211 [TBL] [Abstract][Full Text] [Related]
70. B-Myb overexpression results in activation and increased Fas/Fas ligand-mediated cytotoxicity of T and NK cells. Powzaniuk MA; Trotta R; Loza MJ; Harth A; Iozzo RV; Eisenlohr LC; Perussia B; Calabretta B J Immunol; 2001 Jul; 167(1):242-9. PubMed ID: 11418655 [TBL] [Abstract][Full Text] [Related]
71. Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis. Guo SW; Du Y; Liu X Hum Reprod; 2016 Jul; 31(7):1462-74. PubMed ID: 27130956 [TBL] [Abstract][Full Text] [Related]
72. Che-1 sustains hypoxic response of colorectal cancer cells by affecting Hif-1α stabilization. Bruno T; Valerio M; Casadei L; De Nicola F; Goeman F; Pallocca M; Catena V; Iezzi S; Sorino C; Desantis A; Manetti C; Blandino G; Floridi A; Fanciulli M J Exp Clin Cancer Res; 2017 Feb; 36(1):32. PubMed ID: 28214471 [TBL] [Abstract][Full Text] [Related]
73. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. Lakshmikanth T; Burke S; Ali TH; Kimpfler S; Ursini F; Ruggeri L; Capanni M; Umansky V; Paschen A; Sucker A; Pende D; Groh V; Biassoni R; Höglund P; Kato M; Shibuya K; Schadendorf D; Anichini A; Ferrone S; Velardi A; Kärre K; Shibuya A; Carbone E; Colucci F J Clin Invest; 2009 May; 119(5):1251-63. PubMed ID: 19349689 [TBL] [Abstract][Full Text] [Related]
74. Monocytes and the 38kDa-antigen of mycobacterium tuberculosis modulate natural killer cell activity and their cytolysis directed against ovarian cancer cell lines. Gottschalk N; Lang S; Kimmig R; Singh M; Brandau S BMC Cancer; 2012 Oct; 12():451. PubMed ID: 23036052 [TBL] [Abstract][Full Text] [Related]
75. MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation. Tietje A; Li J; Yu X; Wei Y Gene Ther; 2014 May; 21(5):468-75. PubMed ID: 24572784 [TBL] [Abstract][Full Text] [Related]
76. The association of MHC class I proteins with the 2B4 receptor inhibits self-killing of human NK cells. Betser-Cohen G; Mizrahi S; Elboim M; Alsheich-Bartok O; Mandelboim O J Immunol; 2010 Mar; 184(6):2761-8. PubMed ID: 20164429 [TBL] [Abstract][Full Text] [Related]
77. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Pende D; Cantoni C; Rivera P; Vitale M; Castriconi R; Marcenaro S; Nanni M; Biassoni R; Bottino C; Moretta A; Moretta L Eur J Immunol; 2001 Apr; 31(4):1076-86. PubMed ID: 11298332 [TBL] [Abstract][Full Text] [Related]
78. eEF1Bγ binds the Che-1 and TP53 gene promoters and their transcripts. Pisani C; Onori A; Gabanella F; Delle Monache F; Borreca A; Ammassari-Teule M; Fanciulli M; Di Certo MG; Passananti C; Corbi N J Exp Clin Cancer Res; 2016 Sep; 35(1):146. PubMed ID: 27639846 [TBL] [Abstract][Full Text] [Related]
79. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells. Toutirais O; Cabillic F; Le Friec G; Salot S; Loyer P; Le Gallo M; Desille M; de La Pintière CT; Daniel P; Bouet F; Catros V Eur J Immunol; 2009 May; 39(5):1361-8. PubMed ID: 19404979 [TBL] [Abstract][Full Text] [Related]
80. Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells. Coudert JD; Zimmer J; Tomasello E; Cebecauer M; Colonna M; Vivier E; Held W Blood; 2005 Sep; 106(5):1711-7. PubMed ID: 15886320 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]